Shelter Pharma (BOM:543963) Debt-to-Asset : 0.03 (As of Sep. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Shelter Pharma Debt-to-Asset?

Shelter Pharma's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹1.0 Mil. Shelter Pharma's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₹10.1 Mil. Shelter Pharma's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Sep. 2024 was ₹429.8 Mil. Shelter Pharma's debt to asset for the quarter that ended in Sep. 2024 was 0.03.

Shelter Pharma Debt-to-Asset Historical Data

The historical data trend for Shelter Pharma's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shelter Pharma Debt-to-Asset Chart

Shelter Pharma Annual Data

Trend

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Asset

0.02

0.01

0.08

0.02

Shelter Pharma Semi-Annual Data
	Mar20	Mar21	Mar22	Sep22	Mar23	Sep23	Mar24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial			-	0.08	0.01	0.02	0.03

Competitive Comparison of Shelter Pharma's Debt-to-Asset

For the Drug Manufacturers - Specialty & Generic subindustry, Shelter Pharma's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Shelter Pharma's Debt-to-Asset Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shelter Pharma's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Shelter Pharma's Debt-to-Asset falls into.

Save Embed

;

Save Embed

;

Shelter Pharma Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Shelter Pharma's Debt-to-Asset for the fiscal year that ended in Mar. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(0.041	+	5.732)	/	379.148
	=	0.02

Shelter Pharma's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(1.033	+	10.142)	/	429.787
	=	0.03

Shelter Pharma (BOM:543963) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Shelter Pharma Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Shelter Pharma's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Shelter Pharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shelter Pharma Ltd (BOM:543963) » Definitions » Debt-to-Asset

Traded in Other Exchanges

N/A

Address

Opp. MJ Library Ashram Road, 5th Floor, 501 Sakar 4, Paldi, Ellisbridge, Ahmedabad, GJ, IND, 380006

Website

https://www.shelter.co.in

Shelter Pharma Ltd focuses in manufacturing herbal products with a well-built presence in Human Pharma as well as the Veterinary space. It is present in most of the non-critical segments of human and veterinary pharma through its well-spread portfolio. Its products include tablets, syrups, baby drops, barley water, oils, powders, ointments, etc.

Shelter Pharma Headlines

No Headlines